Related Experiment Video
Updated: Dec 20, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Beta-Hemolytic Streptococcal Infective Endocarditis: Characteristics and Outcomes From a Large, Multinational Cohort
Núria Fernández Hidalgo1, Amal A Gharamti2, María Luisa Aznar1
1Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Insights
Beta-hemolytic streptococci infective endocarditis (IE) presents acutely with a higher risk of stroke and mortality compared to viridans streptococci IE. Implantable cardiac devices are a more frequent predisposing factor in BHS IE.
Area of Science:
- Cardiology
- Infectious Diseases
- Microbiology
Background:
- Beta-hemolytic streptococci (BHS) are an infrequent cause of infective endocarditis (IE).
- Understanding BHS IE clinical features and outcomes is crucial for patient management.
Purpose of the Study:
- To describe the clinical characteristics and outcomes of patients with BHS IE.
- To compare BHS IE with viridans streptococcal IE (VGS IE) in a large multinational cohort.
Main Methods:
- Prospective cohort study using the International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) database.
- Inclusion of 1336 definite cases of streptococcal IE across 64 sites in 28 countries.
- Standardized data collection using a common case report form.
Main Results:
- 147 cases of BHS IE and 823 cases of VGS IE were identified.
- BHS IE patients showed higher rates of native valve disease, congenital heart disease, and implantable cardiac device predisposition.
- BHS IE was associated with acute presentation, fever, stroke, systemic emboli, and significantly higher in-hospital mortality compared to VGS IE.
Conclusions:
- BHS IE presents acutely with increased risks of stroke, systemic emboli, and in-hospital mortality compared to VGS IE.
- Implantable cardiac devices are a more common predisposing factor in BHS IE.
- These findings highlight distinct clinical profiles and outcomes for BHS IE.
Background:
Beta-hemolytic streptococci (BHS) are an uncommon cause of infective endocarditis (IE). The aim of this study was to describe the clinical features and outcomes of patients with BHS IE in a large multinational cohort and compare them with patients with viridans streptococcal IE.
Methods:
The International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) is a large multinational database that recruited patients with IE prospectively using a standardized data set. Sixty-four sites in 28 countries reported patients prospectively using a standard case report form developed by ICE collaborators.
Results:
Among 1336 definite cases of streptococcal IE, 823 were caused by VGS and 147 by BHS. Patients with BHS IE had a lower prevalence of native valve (P < .005) and congenital heart disease predisposition (P = .002), but higher prevalence of implantable cardiac device predisposition (P < .005). Clinically, they were more likely to present acutely (P < .005) and with fever (P = .024). BHS IE was more likely to be complicated by stroke and other systemic emboli (P < .005). The overall in-hospital mortality of BHS IE was significantly higher than that of VGS IE (P = .001). In univariate analysis, variables associated with in-hospital mortality for BHS IE were age (odds ratio [OR], 1.044; P = .004), prosthetic valve IE (OR, 3.029; P = .022), congestive heart failure (OR, 2.513; P = .034), and stroke (OR, 3.198; P = .009).
Conclusions:
BHS IE is characterized by an acute presentation and higher rate of stroke, systemic emboli, and in-hospital mortality than VGS IE. Implantable cardiac devices as a predisposing factor were more often found in BHS IE compared with VGS IE.
More Related Videos
07:50An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies